Today: 19 January 2026
Subscribe
Browse Category

Stock Market News 4 December 2025

Qualcomm (QCOM) Stock on December 4, 2025: AI Momentum, Dividend Record Date and 2026 Forecasts

Qualcomm (QCOM) Stock on December 4, 2025: AI Momentum, Dividend Record Date and 2026 Forecasts

Qualcomm (NASDAQ: QCOM) is back in the spotlight as 2025 winds down. As of the afternoon of December 4, 2025, the stock is trading around $174–175 per share, giving the company a market value of roughly $187 billion. MarketBeat Year‑to‑date total return sits in the mid‑teens, slightly ahead of the broader market but far below the explosive gains seen in…
4 December 2025
····
GE Vernova (GEV) Stock on December 4, 2025: Romania Wind Deal, R&D Surge and Investor Day Risks

GE Vernova (GEV) Stock on December 4, 2025: Romania Wind Deal, R&D Surge and Investor Day Risks

GE Vernova Inc. (NYSE: GEV) continues to be one of 2025’s standout industrial names. By the close on December 4, 2025, the stock was trading around $635 per share, up roughly 5–6% intraday, with a market cap near $163 billion and heavy volume of more than 2.4 million shares. After a blockbuster rally of roughly 75–85% year to date, GE…
4 December 2025
····
Pattern Group Stock (NASDAQ: PTRN) Tanks After Bear Cave Short Report — Latest Price, News and 2026 Forecasts

Pattern Group Stock (NASDAQ: PTRN) Tanks After Bear Cave Short Report — Latest Price, News and 2026 Forecasts

Pattern Group Inc. (NASDAQ: PTRN), the freshly listed ecommerce and AI “accelerator” for consumer brands, just graduated from quiet new listing to full‑blown battleground stock. On Thursday, December 4, 2025, shares slid sharply after short‑selling newsletter The Bear Cave published a critical report questioning Pattern Group’s business model, reliance on Amazon and current valuation. Benzinga The selloff comes barely three…
4 December 2025
···
Polyrizon (PLRZ) Stock Doubles on Naloxone Hydrogel Breakthrough and PL‑14 Manufacturing Milestone – What Investors Need to Know on December 4, 2025

Polyrizon (PLRZ) Stock Doubles on Naloxone Hydrogel Breakthrough and PL‑14 Manufacturing Milestone – What Investors Need to Know on December 4, 2025

Polyrizon Ltd. (NASDAQ: PLRZ) has exploded into the spotlight after a two‑day run that has turned an obscure micro‑cap biotech into one of the most talked‑about healthcare stocks on the Nasdaq. By early afternoon on December 4, 2025, Polyrizon shares were trading around $13–15, nearly doubling from Wednesday’s close at $7.09, with intraday highs reported above $18 and gains briefly…
4 December 2025
····
Dayforce (NYSE: DAY) Stock on December 4, 2025: Thoma Bravo Buyout, Analyst Ratings and Latest Forecasts

Dayforce (NYSE: DAY) Stock on December 4, 2025: Thoma Bravo Buyout, Analyst Ratings and Latest Forecasts

Dayforce, Inc. (NYSE: DAY) stock is trading just below its agreed $70 per‑share cash buyout price from private‑equity firm Thoma Bravo, leaving a narrow merger‑arbitrage spread while investors weigh solid recurring‑revenue growth, mixed earnings, and a broadly “Hold” view from Wall Street analysts as of December 4, 2025. GlobeNewswire This article brings together the latest Dayforce stock news, forecasts, and…
4 December 2025
····
Mastercard (MA) Stock on December 4, 2025: Price, Latest News, Analyst Forecasts and AI‑Payments Outlook

Mastercard (MA) Stock on December 4, 2025: Price, Latest News, Analyst Forecasts and AI‑Payments Outlook

Updated: December 4, 2025 Mastercard Incorporated (NYSE: MA) remains one of the most closely watched large‑cap financial stocks as 2025 winds down. On Thursday, December 4, 2025, Mastercard shares closed just under $545, down about 1.6% on the day, and sit roughly in the middle of their 52‑week range of around $466 to $602. StockAnalysis Despite the pullback, Wall Street’s…
4 December 2025
···
Q/C Technologies (QCLS) Stock Skyrockets on Martin Shkreli’s $100 ‘Quantum-Class’ Call – What’s Really Behind the Rally on December 4, 2025

Q/C Technologies (QCLS) Stock Skyrockets on Martin Shkreli’s $100 ‘Quantum-Class’ Call – What’s Really Behind the Rally on December 4, 2025

Microcap quantum‑class computing and blockchain play Q/C Technologies has doubled in two sessions after Martin Shkreli unveiled a bold $100 price target. Here’s what’s driving QCLS – and the risks behind the hype. QCLS stock today: a tiny name with huge moves By early afternoon on December 4, 2025, shares of Q/C Technologies, Inc. (NASDAQ: QCLS) were trading around $6.7–$6.8,…
4 December 2025
···
PayPal Stock Today: JPMorgan Downgrade, CFO Warning and 2025–2030 Outlook for PYPL

PayPal Stock Today: JPMorgan Downgrade, CFO Warning and 2025–2030 Outlook for PYPL

As of December 4, 2025, PayPal Holdings, Inc. (NASDAQ: PYPL) is back in Wall Street’s crosshairs. A cautious outlook from its CFO and a fresh downgrade from JPMorgan have pushed the stock toward the lower end of its 52‑week range, even as long‑term forecasts and valuation models still point to meaningful upside. Below is a detailed look at the latest…
4 December 2025
···
Thermo Fisher Scientific (TMO) Stock: Fresh Deals, Wall Street Upgrades and Long‑Term Outlook as of December 4, 2025

Thermo Fisher Scientific (TMO) Stock: Fresh Deals, Wall Street Upgrades and Long‑Term Outlook as of December 4, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) is ending 2025 with strong momentum. The life‑science giant’s shares are trading around $570–$575 today, after a powerful rebound from mid‑year lows and a series of bullish analyst upgrades, strategic acquisitions and new partnerships. FinanceCharts This overview pulls together the latest news, forecasts and analyses up to December 4, 2025, to help investors understand…
4 December 2025
····
McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

Updated: December 4, 2025 McDonald’s Corporation (NYSE: MCD) heads into the final stretch of 2025 as one of the market’s core defensive consumer names, but the story is no longer just about burgers and fries. Investors are weighing a fresh dividend hike, aggressive price cuts to win back budget‑strained diners, surging digital engagement, and a crowded field of analyst forecasts…
4 December 2025
·
Procter & Gamble (PG) Stock at 2‑Year Lows: Latest News, Forecasts & Outlook as of 4 December 2025

Procter & Gamble (PG) Stock at 2‑Year Lows: Latest News, Forecasts & Outlook as of 4 December 2025

Key takeaways for Procter & Gamble stock today (4 December 2025) If you’re seeing the name “Procter & Gamble Company (The) 3 stock” on certain European or structured‑product platforms, it typically refers to exposure to the same underlying NYSE‑listed PG shares (often via warrants or certificates) rather than a different class of equity. Gspriips 1. Procter & Gamble stock today:…
4 December 2025
····
Coherent Corp (COHR) Stock Jumps to Fresh Highs on 300mm Silicon Carbide Breakthrough – Price, Forecast & AI Datacenter Outlook as of December 4, 2025

Coherent Corp (COHR) Stock Jumps to Fresh Highs on 300mm Silicon Carbide Breakthrough – Price, Forecast & AI Datacenter Outlook as of December 4, 2025

Coherent Corp (NYSE: COHR) is back in the spotlight. As of early afternoon trading on December 4, 2025, the photonics and materials specialist is trading around $179 per share, up roughly 4.8–5% on the day, after touching an intraday high above $186 on heavy volume. StockAnalysis The move extends a powerful rally driven by AI datacenter demand, a strong earnings…
4 December 2025
··
1 … 1,025 1,026 1,027 1,028 1,029 … 1,468

Stock Market Today

  • Merck Shares Appear Undervalued Despite Recent Price Gains, DCF Model Shows
    January 19, 2026, 3:44 AM EST. Merck's stock closed at $108.83 with a 7.7% return over 30 days and 15.3% over the past year, lagging peers. A discounted cash flow (DCF) model projecting future free cash flows estimates an intrinsic share value of $201.47, suggesting the stock is approximately 46% undervalued. Merck's recent share strength contrasts with market sentiment shaped by drug pipelines, regulation, and healthcare spending. The stock's price-to-earnings (P/E) ratio reflects investor expectations balancing growth and risk. Merck's five-year return stands at 64.8%, while its valuation metrics indicate potential long-term value despite moderate short-term gains.
Go toTop